key: cord-0711327-el0qnnnn
authors: Yesudhas, Dhanusha; Srivastava, Ambuj; Sekijima, Masakazu; Gromiha, M. Michael
title: Tackling Covid‐19 using disordered‐to‐order transition of residues in the spike protein upon angiotensin‐converting enzyme 2 binding
date: 2021-04-30
journal: Proteins
DOI: 10.1002/prot.26088
sha: 1559f62b63e2310516c5d644466078ba71793404
doc_id: 711327
cord_uid: el0qnnnn

The 2019‐novel coronavirus also known as severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) is a common threat to animals and humans, and is responsible for the human SARS pandemic in 2019 to 2021. The infection of SARS‐CoV‐2 in humans involves a viral surface glycoprotein named as spike proteins, which bind to the human angiotensin‐converting enzyme 2 (ACE2) proteins. Particularly, the receptor binding domains (RBDs) mediate the interaction and contain several disordered regions, which help in the binding. Investigations on the influence of disordered residues/regions in stability and binding of spike protein with ACE2 help to understand the disease pathogenesis, which has not yet been studied. In this study, we have used molecular‐dynamics simulations to characterize the structural changes in disordered regions of the spike protein that result from ACE2 binding. We observed that the disordered regions undergo disorder‐to‐order transition (DOT) upon binding with ACE2, and the DOT residues are located at functionally important regions of RBD. Although the RBD is having rigid structure, DOT residues make conformational rearrangements for the spike protein to attach with ACE2. The binding is strengthened via hydrophilic and aromatic amino acids mainly present in the DOTs. The positively correlated motions of the DOT residues with its nearby residues also explain the binding profile of RBD with ACE2, and the residues are observed to be contributing more favorable binding energies for the spike‐ACE2 complex formation. This study emphasizes that intrinsically disordered residues in the RBD of spike protein may provide insights into its etiology and be useful for drug and vaccine discovery.

respiratory diseases and gastroenteritis in animals and humans. 1 The SARS-CoV and SARS-CoV-2 belong to the betacoronavirus family, and share 80% whole genome sequence similarity. 2 At the time of viral invasion, spike protein ($1300 amino acid residues) is cleaved by host cell proteases into S1 (the peripheral fragment) and S2 (membrane-spanning fragment) subunits. The S1

subunit contains the receptor binding domain (RBD), which facilitates the interactions with host cell receptors whereas, the S2 subunit fuses with host cell membrane and releases the viral genome into the cell 2, 3 ( Figure S1 ). The heptads repeat regions N-HR, C-HR and the fusion peptides are involved in membrane fusion. The viral entry to the host cells takes place by an endocytic and nonendosomal pathways. 4 The spike protein priming by furin at the S1/S2 site is important and unique in SARS-CoV-2 membrane fusion, which is absent in SARS-CoV. 5 Spike proteins have a good binding affinity for sugar receptors of human cells, which uses them as a mechanism of cell entry. 6 Notably, an SARS-CoV-2 has a stronger affinity to human ACE2 than an SARS-CoV. SARS-CoV-2 also has a higher pathogenicity and mortality rate than SARS-CoV. The clinical spectrum of SARS-CoV-2 is broader than SARS-CoV including asymptomatic infections, mild upper respiratory tract illness, severe viral pneumonia with respiratory failure and death. In addition, SARS-CoV-2 infected patients suffer prolonged illness and have a low neutralizing antibody capacity, suggesting a greater need for vaccine interventions. 7 The intrinsic disorder regions (IDRs) are the regions, which have a dynamic ensemble of conformations that do not adopt stable threedimensional structure in physiological conditions. 8 IDRs are known to be involved in many biological functions, including signaling, regulation and binding molecules including proteins, DNA, RNA and small molecules. IDPs are known to be associated with various diseases including neurological disorders and cancer. 9, 10 IDPs also tune their binding affinity for specific and non-specific binding with other molecules by changing its conformation. 9, 11 They also act as hub proteins in various signaling networks, bind multiple partners and are involved in many pathways. 12, 13 IDRs are reported in SARS and other coronaviruses, for example, in human coronavirus 229E (hCoV-229E) an intrinsically disordered domain present near the C-terminal tail peptide, plays an important role in dimer-dimer association. Similarly, coronavirus HKU1 has a large structurally conserved linker loop (amino acids 428-587), which is partially disordered. 14 The S2 subunit of HKU1 also shows the presence of disordered residues at its protease cleavage site. 15 The structure reported for the recent SARS-CoV-2 spike protein, shows that S1/S2 junction is in a disordered, solvent-exposed loop. 1 Based on the literature reports, more number of databases and tools have been developed for predicting the disordered regions in proteins. [16] [17] [18] For example, the DisProt database contains the disorder content of spike and other viral protein structures. 17 Wrapp et al determined the structure of the pre-fusion spike trimeric protein using cryogenic electron microscopy at a resolution of 3.46 Å (PDB ID: 6VSB). 1 In this trimeric protein, many residues are missing their structural coordinate information in the RBD (residues 329-334, 444-448, and 455-490), especially in "A" chain, which has an elevated structure and is primarily responsible for binding. The 329 to 334 residues are present at the N-terminal of RBD and disordered in free protein as well as in the complex and are termed as DR (disordered residues). However, the intrinsic disordered residues 444 to 448 and 455 to 490 have stable structure upon ACE2 binding (PDB ID: 6M0J) 19 and are termed as disorder-to-order transition (DOT) residues. Despite the lack of a stable three-dimensional structure of these regions in free protein, the DOTs facilitate the spike-ACE2 recognition and help for both the proteins interactions.

On the other hand, coronavirus spike protein is a glycoprotein, and the glycosylation site has high flexibility and variable secondary structures. 20 The infection and pathogenicity are often associated with the disordered regions in the viral proteins. [22] [23] [24] [25] However, the role of disordered residues/regions in stability and binding of spike protein with ACE2, which could help in understanding the disease pathogenesis,

has not yet been explored. In this work, we investigate the importance of disordered residues in spike-ACE2 recognition using molecular dynamics (MD) simulations. We observed that the DOTs in the free form of the spike protein experience very high fluctuations more than the complex structure. The DOTs undergo a structural transition upon binding with ACE2, which facilitates the stable compact complex structure. In addition, DOT regions are also contributing significant binding energy upon interactions with ACE2 receptors. Our study helps in understanding the functionality of IDRs in spike protein, and its interactions with host cell proteins.

A region is considered to be disordered if at least five continuous non-terminal residues are missing in the PDB structure. 26, 27 The DOT residues in RBD domain are obtained by comparing the missing residues from free protein (PDB ID: 6VSB) and spike-ACE2 complex (PDB ID: 6M0J). We observed that the A chain of 6VSB is an elevated structure and it contains missing residues from 444 to 448 and 455 to 490, which obtained an ordered structure upon binding to the ACE2 receptor (PDB ID: 6M0J). Thus, in this study, the residues 444 to 448 are considered as DOT1 and 455 to 490 as DOT2.

To obtain the structures for missing residues of the RBD present in free spike protein we have used modeler version 9.24 28 software and generated 10 models and selected the model, which has the lowest discrete optimized protein energy score. The missing residues (DOT residues) of the prefusion structure were modeled using 6VSB as a template.

MD simulations are performed for free spike protein and the complex with ACE2 for 100 ns using AMBER18 tools with FF14SB 29 and GAFF force fields. 30 We have repeated the simulations three times to evaluate the consistency of results. The repetitions have been carried out with a seed generated from a random number generator and hence the initial velocities for each system are different. Molecule is solvated using TIP3PBOX water model with edge of the box at least 10 Å away from the solute molecules. 31 The Na + ions are added to neutralize the system in order to maintain the physiological condition.

Energy minimization of each molecule is done for 50 000 steps using the steepest descent minimization with the step size of 2 fs at constant temperature (300 K), and pressure (1 atm). The description of the simulation systems has been listed in Table S1 .

The trajectories obtained from simulations are visualized using VMD, 32 Pymol, 33 and Chimera. 34 Properties such as root mean square fluctuation (RMSF) and root mean square deviation (RMSD) are calculated using "rms" and "atomicfluct" commands available in CPPTRAJ program, respectively. The average minimum distance is calculated by plotting the distance of each residue in spike RBD with ACE2 during the simulation using "nativecontacts" command and generating average value using a python program. The interaction energy between spike and ACE2 is calculated using the the molecular mechanics-Poisson Boltzmann surface area (MMPBSA) 35 program for the last 2 ns. The dynamic residue movement is monitored via the dynamic cross-correction map (DCCM) using the Bio3D package. 36 

MM-PBSA method is applied to calculate the binding free energy between RBD of spike protein and the ACE2 receptor. The energy contribution of each residue toward binding is measured.

where E bond , E el , and E vdW are the molecular mechanics (MM) energy terms from bonded (bond length, angle, and dihedral), electrostatic, and van der Waals interactions, respectively. G pol and G np are the polar and nonpolar contributions, respectively, to the solvation free energies. TS is the absolute temperature, T, multiplied by the entropy, S.

where ΔG complex represents the free energy of a protein-protein complex, and ΔG protein1 and G protein2 are the free energies of RBD and ACE2 proteins, respectively.

Recognition and interaction of spike with ACE2 is regulated by the RBD (319-541), in which residues from 436 to 506 are termed as receptor binding motif (RBM) because these residues are actively participating in the interactions. The DOT1 (residues 444-448) and

DOT2 (residues 455-490) are grouped in the RBM motif which is responsible for ACE2 recognition. As shown in Figures 1 and S1 , the DOT1 and DOT2 are located in the interface of the spike protein and ACE2. The crucial interacting DOT residues as well the residues, which are important to maintain the binding conformation, are heighted in Figure 1 . showing lesser distance with ACE2 (Table 1) . Particularly, the hot spot residues (Lue455, Glu484, Phe486, Asn487, Tyr489, Gln493, Gly496, Asn501, and Gly502), which are mentioned in the literature 38-41 maintain less than 3 Å distance from ACE2 (Table 1 and Figure 1 ). The average minimum distance between the spike RBD and ACE2 has been computed for the three repetitions of simulations, and the results are observed to be consistent ( Figure S6 ). The location and the flexibility of these DOT residues provide better shape comple- Likewise, the binding free energy contribution from each residue of the RBD domain is calculated using AMBER-MMPBSA. As expected, the residues, which are maintaining lesser distance with ACE2 are showing more favorable interaction energies. The ordered and the disordered residues and their interaction energies are given in Figure 4B and are also listed in Table 1 . Particularly, the residues located at the flanking regions of DOTs are shown to be contributing more favorable interaction energies. Among the ordered residues in the interface, seven residues are maintaining less than 3 Å distance with ACE2 and contributing more for the binding energy whereas among DOT residues, six of them are contributing favorable binding free energies. The alanine scanning mutagenesis of DOT residues has been performed to examine the change in binding free energy of the complex. The mutation of DOT residues Leu455, Phe456, Phe486, and Tyr489 decreased the binding affinity between spike RBD and ACE2, which confirms the importance of these residues in maintaining the binding affinity of the complex ( Figure S7 ).

The DOT2, which makes the longest interacting loop region, is rich in Phe (11%) residues. This aromatic amino acid makes bonded and nonbonded interactions with the other aromatic residues of the partner ACE2 protein ( Figure 1B) . The residues involved in hydrogen bond interactions between the DOTs and ACE2 receptors are reported in Table 2 , and the other hydrophobic interactions are listed in Table S2 .

Mainly, the residues present in RBD of spike protein Ala475, Gly476,

The residue fluctuation of spike protein receptor binding domain (RBD). The DOT1 and DOT2 residues are marked by black line below the X-axis. The, secondary structure information is displayed above the X-axis. The symbols α, β, η, and T represent α-helix, β-strand, 3 10helix, and turn, respectively Asn487, and Tyr489 are making interactions with Ser19, Gln24 and Tyr83 of ACE2 ( Table 2) . 43 In the current study, these residues form hydrogen bonds and other non-covalent interactions (Tables 2 and S2) . Notably, the decomposition energy calculations also stated that glycine, tyrosine, and phenylalanine residues are contributing favorable affinities for the complex structure. However, a recent study revealed that in SARS-CoV RBD, the tyrosine residues, which are present at the interface (Tyr442, Tyr475, and Tyr491), are not actively taking part in the interaction with ACE2. 43 Whereas in SARS-CoV-2, even though the Tyr and Phe residues of the DOT2 are present in the loop, they are still stable via pi-pi interactions of their phenyl ring structures, for example, Phe486 of spike protein interacts with Tyr83 of ACE2. These residues are actively taking part in intraprotein and interprotein interactions. Figure 1B represents the binding interface, in which all the Gly, Phe, and Tyr residues in DOT2 are marked in silver, red, and green, respectively, and the conserved residues are also marked in yellow. The side chains of Tyr and Phe of spike protein make favorable T A B L E 1 Residues, which are less than 3 Å distance from ACE2 and their energetic contribution upon binding The key residues reported in the literature. Conserved residues among SARS-CoV-2, NL-63, and SARS-CoV are in bold.

F I G U R E 4 A, The average minimum distance (deviations are indicated with error bars) and, B, the decomposition energy of each residue between the receptor binding domain (RBD) residues against angiotensin-converting enzyme 2 (ACE2) throughout the simulations. Secondary structures of residues are the same as in Figure 3 electrostatic interactions with α1 helix of ACE2, especially with Tyr and Gln amino acids (Table 2) showing positive correlated motion. However, in Figure 5B , the DOT residues of the free protein (marked in red circle) are not having positively correlated motion with the nearby residues, which explains its higher structural flexibility (Figure 2) . Similarly, the residue contact plot also explained that the crucial DOT residues are maintaining the interactions with ACE2 throughout the simulations ( Figure S8 ).

The host cell invasion of SARS-CoV-2 is happening by glyco- inhibitors. In addition, these spike protein DOT residues act as potential epitope residues for designing new antibodies. Thus, an atomic level characterization of the spike protein and its unique DOTs structure can guide for mechanism study, which is associated with its transmission. The inhibition of viral entry needs to focus on the structural aspects of DOTs in spike RBD domain, which may help in therapeutic applications for COVID-19. 

The authors declare no conflicts of interest. 

The peer review history for this article is available at https://publons. com/publon/10.1002/prot.26088.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

M. Michael Gromiha https://orcid.org/0000-0002-1776-4096

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Structural and functional basis of SARS-CoV-2 entry by using human ACE2

Coronaviruses-drug discovery and therapeutic options

COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics. Infection

Structure, function, and evolution of coronavirus spike proteins

Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptorbinding domain recognition and host cell infection with support of cellular serine proteases

Intrinsically disordered proteins in cellular signaling and regulation

Intrinsically disordered proteins: regulation and disease

Deciphering RNA-recognition patterns of intrinsically disordered proteins

Unified understanding of folding and binding mechanisms of globular and intrinsically disordered proteins

Conformational recognition of an intrinsically disordered protein

The multifaceted roles of intrinsic disorder in protein complexes

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Pre-fusion structure of a human coronavirus spike protein

D 2 P 2 : database of disordered protein predictions

DisProt: a database of protein disorder

MobiDB 2.0: an improved database of intrinsically disordered and mobile proteins

Structure of the SARS-CoV-2 spike receptorbinding domain bound to the ACE2 receptor

Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding

Beyond shielding: the roles of Glycans in the SARS-CoV-2 spike protein

Intrinsically disordered side of the Zika virus proteome

Viral disorder or disordered viruses: do viral proteins possess unique features?

Deciphering the dark proteome of Chikungunya virus

Understanding covid-19 via comparative analysis of dark proteomes of sars-cov-2, human sars and bat sars-like coronaviruses

PrDOS: prediction of disordered protein regions from amino acid sequence

Understanding protein non-folding

Comparative protein structure modeling using modeller

ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB

Development and testing of a general amber force field

Comparison of multiple amber force fields and development of improved protein backbone parameters

VMD: visual molecular dynamics

UCSF ChimeraX: meeting modern challenges in visualization and analysis

Py: an efficient program for end-state free energy calculations

Bio3d: an R package for the comparative analysis of protein structures

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Why are ACE2 binding coronavirus strains SARS-CoV/SARS-CoV-2 wild and NL63 mild?

Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein

Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies

Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains

Biophysical characterization of the SARS-CoV2 spike protein binding with the ACE2 receptor explains increased COVID-19 pathogenesis

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Unexpected receptor functional mimicry elucidates activation of coronavirus fusion

Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen

Tackling Covid-19 using disordered-to-order transition of residues in the spike protein upon angiotensinconverting enzyme 2 binding